Do I need to treat Staphylococcus haemolyticus found in a urine culture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment of Staphylococcus haemolyticus in Urine

Do not treat Staphylococcus haemolyticus bacteriuria unless the patient has both acute urinary symptoms (dysuria, frequency, urgency, fever >38.3°C, or gross hematuria) AND pyuria (≥10 WBCs/HPF or positive leukocyte esterase). 1, 2

Diagnostic Algorithm

Step 1: Assess for Specific Urinary Symptoms

  • Required symptoms include: acute-onset dysuria, urinary frequency, urgency, fever >38.3°C, gross hematuria, or suprapubic pain 1, 2
  • Non-specific symptoms that do NOT justify treatment: confusion, falls, functional decline in elderly patients, or cloudy/malodorous urine alone 1
  • If no specific urinary symptoms are present: this represents asymptomatic bacteriuria and should NOT be treated 1, 2, 3

Step 2: Confirm Pyuria

  • Pyuria must be present: ≥10 white blood cells per high-power field on microscopy OR positive leukocyte esterase test 1, 2
  • Without pyuria: urinary tract infection is unlikely even with symptoms, and treatment should be withheld 1

Step 3: Evaluate Patient Risk Factors

Staphylococcus haemolyticus is an opportunistic pathogen typically found in specific contexts 4, 5:

  • Recent urinary catheterization (present in 82% of staphylococcal bacteriuria cases) 6
  • Urological abnormalities or recent instrumentation 7, 6
  • Immunocompromised states: diabetes, malignancy, stroke, advanced age (>66 years) 4
  • Male sex and older age 7

When Treatment IS Indicated

Treat only when ALL of the following are met:

  1. Acute urinary symptoms present (dysuria, frequency, urgency, fever, hematuria) 1, 2
  2. Pyuria confirmed (≥10 WBCs/HPF or positive leukocyte esterase) 1, 2
  3. Pure culture of S. haemolyticus from properly collected specimen 1
  4. Patient has risk factors (catheterization, urological abnormality, immunocompromise) 7, 6, 4

Antibiotic Selection

Based on susceptibility data, S. haemolyticus is typically susceptible to 4, 5:

  • Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 7-14 days (first-line if susceptible) 4, 5
  • Nitrofurantoin 100 mg twice daily for 5-7 days (if susceptible and normal renal function) 4
  • Vancomycin (reserved for resistant isolates or severe infection) 4

Duration: 7-14 days for complicated UTI or when urological abnormalities are present 2, 3

Special Considerations

Before Urological Procedures

  • Screen for and treat S. haemolyticus bacteriuria prior to endoscopic urologic procedures with anticipated mucosal trauma (e.g., transurethral resection, ureteroscopy) 1, 2, 3
  • This is the primary exception where asymptomatic bacteriuria should be treated 1, 3

Catheterized Patients

  • Do NOT screen or treat asymptomatic bacteriuria in patients with short-term (<30 days) or long-term indwelling catheters 2, 3
  • Bacteriuria and pyuria are nearly universal in catheterized patients (approaching 100%) 2
  • Only evaluate if: fever, hypotension, rigors, or suspected urosepsis develops 2, 3

Risk of Bacteremia

  • S. aureus (closely related species) bacteriuria is associated with subsequent bacteremia in 13% of cases at initial isolation and 11% during follow-up 6
  • Consider blood cultures if: patient has fever, hemodynamic instability, or recent urological instrumentation 7, 6
  • However, routine blood cultures are NOT recommended in well, asymptomatic patients 7

Critical Pitfalls to Avoid

  1. Never treat based on positive culture alone without symptoms and pyuria—this represents asymptomatic bacteriuria in 15-50% of elderly patients 1

  2. Do not treat non-specific geriatric symptoms (confusion, falls) without acute urinary symptoms—treatment provides no benefit and increases antimicrobial resistance 1

  3. Avoid routine screening in catheterized patients—bacteriuria is universal and treatment increases resistance without preventing symptomatic infection 2, 3

  4. Ensure proper specimen collection—contamination is common; use midstream clean-catch or catheterization for definitive diagnosis 1, 8

  5. Do not assume all coagulase-negative staphylococci are contaminants—S. haemolyticus can cause true infection in immunocompromised hosts and requires proper identification 4, 5

Harms of Unnecessary Treatment

Treating asymptomatic S. haemolyticus bacteriuria causes 1, 2, 1:

  • Increased antimicrobial resistance at individual and health system levels
  • Clostridioides difficile infection risk
  • Adverse drug effects without clinical benefit
  • Reinfection with more resistant organisms
  • No reduction in symptomatic UTI, renal injury, or mortality 1

References

6
Research

Isolation of Staphylococcus aureus from the urinary tract: association of isolation with symptomatic urinary tract infection and subsequent staphylococcal bacteremia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006

Related Questions

Is Staphylococcus hemolyticus in urine significant?
Do you treat a urinary tract infection with 20-30,000 colony count of Staphylococcus simulans?
What is the recommended treatment for a patient with Staphylococcus species (Staphylococcus sp) on urine culture?
In a previously healthy infant younger than three months, is Staphylococcus aureus subsp. aureus isolated from urine a true pathogen or a contaminant?
What is the recommended treatment for an 80-year-old patient with a urine culture positive for Staphylococcus aureus and symptoms of dysuria (urine burning)?
After surviving a ventricular‑fibrillation cardiac arrest, how long must the patient refrain from driving and what cardiac criteria (e.g., implantable cardioverter‑defibrillator status, left‑ventricular ejection fraction ≥35%, absence of recent appropriate ICD therapies) are required for medical clearance to resume driving?
How should I manage a patient with a confirmed statin allergy who still requires lipid‑lowering therapy?
Can I reduce fluoxetine (Prozac) from 40 mg to 20 mg?
How often should I check a patient's vitamin D level?
What blood tests should be obtained to evaluate and monitor a patient with thyroid cancer?
Is there a relationship between cardiomyopathy and polycythemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.